Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 199

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

CD8 T Cells Utilize TRAIL to Control Influenza Virus Infection

Open access
Brincks, Erik L, Katewa, Arna, Kucaba, Tamara A, Griffith, Thomas S, Legge, Kevin L·2008·The Journal of Immunology

Abstract

Elimination of influenza virus-infected cells during primary influenza virus infections is thought to be mediated by CD8+ T cells though perforin- and FasL-mediated mechanisms. However, recent studies suggest that CD8+ T cells can also utilize TRAIL to kill virally infected cells. Therefore, we herein examined the importance of TRAIL to influenza-specific CD8+ T cell immunity and to the control of influenza virus infections. Our results show that TRAIL deficiency increases influenza-associated morbidity and influenza virus titers, and that these changes in disease severity are coupled to decreased influenza-specific CD8+ T cell cytotoxicity in TRAIL−/− mice, a decrease that occurs despite equivalent numbers of pulmonary influenza-specific CD8+ T cells. Furthermore, TRAIL expression occurs selectively on influenza-specific CD8+ T cells, and high TRAIL receptor (DR5) expression occurs selectively on influenza virus-infected pulmonary epithelial cells. Finally, we show that adoptive transfer of TRAIL+/+ but not TRAIL−/− CD8+ effector T cells alters the mortality associated with lethal dose influenza virus infections. Collectively, our results suggest that TRAIL is an important component of immunity to influenza infections and that TRAIL deficiency decreases CD8+ T cell-mediated cytotoxicity, leading to more severe influenza infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.181.7.4918

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 42

  1. 1984, In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific, 814
  2. 1996, Cytotoxic T cell effector and memory function in viral immunity, 1
  3. 1997, CD8+ T cells clear influenza virus by perforin or Fas-dependent processes, 5197
  4. 1998, Mechanism of protective immunity against influenza virus infection in mice without antibodies, 322
  5. 1998, Clearance of an influenza A virus by CD4+ T cells is inefficient in the absence of B cells, 882
  6. 2007, Heterogeneity of effector phenotype for acute phase and memory influenza A virus-specific CTL, 64
  7. 2004, Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity, 2418
  8. 1996, Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family, 12687
  9. 2001, Production of interferon-γ by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology, 119
  10. 2003, Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand, 9156
  11. 1999, IFN-γ mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression, 920
  12. 2001, Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l, 11128
  13. 2005, Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs, 425
  14. 2002, Characterization of the in vivo function of TNF-α-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice, 2246
  15. 2005, DR5 knockout mice are compromised in radiation-induced apoptosis, 2000
  16. 2003, Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection, 265
  17. 2005, Lymph node dendritic cells control CD8+ T cell responses through regulated FasL expression, 649
  18. 2000, A previously unrecognized H-2Db-restricted peptide prominent in the primary influenza A virus-specific CD8+ T-cell response is much less apparent following secondary challenge, 3486
  19. 2005, Vaccination with an acidic polymerase epitope of influenza virus elicits a potent antiviral T cell response but delayed clearance of an influenza virus challenge, 696
  20. 2006, A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequencies, 994
  21. 2005, Histone deacetylase inhibitors modulate renal cell carcinoma sensitivity to TRAIL/Apo-2L-induced apoptosis by enhancing TRAIL-R2 expression, 1104
  22. 2004, Activation, differentiation, and migration of naive virus-specific CD8+ T cells during pulmonary influenza virus infection, 1209
  23. 2004, Receptor for advanced glycation end-products is a marker of type I lung alveolar cells, 165
  24. 1996, Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes, 5555
  25. 1998, Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells, 1492
  26. 2000, Early programming of T cell populations responding to bacterial infection, 6833
  27. 2001, The CD8 response on autopilot, 381
  28. 2006, Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells, 248
  29. 2007, Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage, 667
  30. 2005, Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice, 7658
  31. 2005, Frequency, specificity, and sites of expansion of CD8+ T cells during primary pulmonary influenza virus infection, 5332
  32. 2002, TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections, 659
  33. 2000, Measles virus induces functional TRAIL production by human dendritic cells, 556
  34. 2001, Antiviral response by natural killer cells through TRAIL gene induction by IFN-α/β, 3138
  35. 2008, Cutting edge: Engagement of NKG2A on CD8+ effector T cells limits immunopathology in influenza pneumonia, 25
  36. 2000, Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans, 6105
  37. 1995, Interferons, Mx genes, and resistance to influenza virus, S67
  38. 2007, Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo, 9790
  39. 2003, Plasmacytoid dendritic cell-derived IFN-α induces TNF-related apoptosis-inducing ligand/Apo-2L-mediated antitumor activity by human monocytes following CpG oligodeoxynucleotide stimulation, 212
  40. 2006, TRAIL expression up-regulated by interferon-γ via phosphorylation of STAT1 induces myeloma cell death, 4115
  41. 1999, Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL, 1343
  42. 2005, Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104, 359

Cited by

See all 199

Metadata

Authors
Brincks, E. L., Katewa, A., Kucaba, T. A., Griffith, T. S., & Legge, K. L.
Venue
The Journal of Immunology
Published
2008-10-01
Volume
181
Issue
7
Pages
4918-4925
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2139759276
Cited by
199
References
3
FWCI
7.88
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CD8 T Cells Utilize TRAIL to Control Influenza Virus Infection. https://app.cochat.ai/papers/10.4049/jimmunol.181.7.4918
The paper
Brincks, E. L., Katewa, A., Kucaba, T. A., Griffith, T. S., & Legge, K. L. (2008). CD8 T Cells Utilize TRAIL to Control Influenza Virus Infection. The Journal of Immunology. https://doi.org/10.4049/jimmunol.181.7.4918

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.